Imperial College London
Portrait Picture

DrCandiceRoufosse

Faculty of Medicine, Department of Immunology and Inflammation

Clinical Reader in Renal Pathology
 
 
 
//

Contact

 

+44 (0)20 3313 3280c.roufosse

 
 
//

Location

 

Commonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Randhawa:2019:10.1111/ajt.15114,
author = {Randhawa, P and Roufosse, C},
doi = {10.1111/ajt.15114},
journal = {American Journal of Transplantation},
pages = {622--624},
title = {The expanding spectrum of antibody-mediated rejection: should we include cases where no anti-HLA donor-specific antibody is detected?},
url = {http://dx.doi.org/10.1111/ajt.15114},
volume = {19},
year = {2019}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Antibody-mediated rejection (ABMR) in a renal transplant biopsy is most often diagnosed by a combination of microvascular injury (MVI), C4d deposition and presence of circulating DSA. MVI designates the leucocyte margination reaction in glomeruli (glomerulitis, Banff score g) and in peritubular capillaries (peritubular capillaritis, Banff score ptc). MVI (sum of Banff scores g+ptc) is a morphological feature rather than a diagnosis, and is not specific for ABMR.
AU  - Randhawa,P
AU  - Roufosse,C
DO  - 10.1111/ajt.15114
EP  - 624
PY  - 2019///
SN  - 1600-6135
SP  - 622
TI  - The expanding spectrum of antibody-mediated rejection: should we include cases where no anti-HLA donor-specific antibody is detected?
T2  - American Journal of Transplantation
UR  - http://dx.doi.org/10.1111/ajt.15114
UR  - https://www.ncbi.nlm.nih.gov/pubmed/30203616
UR  - http://hdl.handle.net/10044/1/62730
VL  - 19
ER  -
Download